Corvex (MOVE) reported a third-quarter loss of $0.60 per share on revenue of $4.98 million in its first full quarter as a pure-play AI infrastructure company. There was no consensus estimate to measure against. The year-over-year comparisons, earnings growth of 87.3% and revenue growth of 6127.5%, are mathematically accurate but say little about the business. The prior-year period reflects only the divested legacy healthcare operation. The narrower per-share loss mostly reflects weighted shares rising from about 1.2 million to 29.0 million, not better economics. The more useful comparison is sequential, and it tells a split story. Revenue rose 31% from $3.8 million in the second quarter, but contracted ARR on live compute was essentially flat at about $21.7 million versus roughly $22 million in August. That is the central tension: Corvex executed the steps it promised, but the revenue engine has not yet grown. The next leg depends on capacity that is not yet live and offtake deals that are not yet signed.

The quality of the quarter deserves scrutiny. GAAP net loss widened to $17.5 million from $12.8 million in the second quarter. Stock-based compensation of $11.3 million was the largest driver, and $9.3 million of it sat in general and administrative expense. Adjusted EBITDA held flat at a loss of $3.2 million, so the core cash-earnings profile neither improved nor deteriorated. Unit economics remain thin at this scale. AI platform cost of revenue ($2.5 million) plus depreciation and amortization ($2.9 million) exceeded the $5.0 million of revenue. Operating cash use rose to $7.0 million from $5.3 million. Deferred revenue slipped to $3.2 million from $3.7 million, which tempers management's point about rising customer prepayments. The balance sheet is also dominated by acquisition accounting: $519 million of the $628 million in total assets is goodwill.

On the call, management's tone was clearly more confident, and the operating checklist moved forward:

• **Capacity:** The roughly 8 MW plan set out in August is now fully secured, and the call cited 7.7 MW under contract. The Mid-Atlantic 1 expansion and Midwest-1 remain on track to be ready for service in the fourth quarter.
• **Token Factory:** The serverless inference platform launched publicly on September 30 as scheduled. Management expects it to produce meaningful revenue in 2027.
• **Pricing:** Management described higher spot and committed GPU pricing, rising prepayment percentages and repricing opportunities on legacy server renewals.
• **Contract structure:** All AI revenue comes from take-or-pay contracts, which adds some visibility.

Investors should separate secured capacity from monetized capacity. The release says Corvex is still "working to complete offtake" for the 1.6 MW Blackwell cluster at Mid-Atlantic 1 and the 4.5 MW at Midwest-1. Management described the Mid-Atlantic deal, a three-year agreement for more than 1,000 Blackwells with an AI-native customer, as in final discussions. It described talks for the full Midwest-1 site with a creditworthy counterparty as encouraging.

Those two agreements are the dominant catalyst, along with the right of first refusal on another 12.5 MW that could take capacity above 20 MW in 2027. Bears have legitimate ammunition, however:

• **Timing:** Revenue lags ready-for-service dates because hardware must be delivered, commissioned and accepted.
• **Funding:** Filling 6 MW-plus will require more capital.
• **Dilution:** As-converted shares climbed to about 60.9 million from 56.6 million, and an unused at-the-market facility adds overhang.
• **Debt:** Corvex took on $7.5 million of non-recourse equipment debt at roughly 10%, with about $6.9 million outstanding.
• **Other risks:** Customer concentration persists, a material weakness remains unremediated, and management flagged landlords tightening tenant credit requirements.

Funding is adequate for now. Cash rose to $42.0 million after a private placement of about $33 million gross at $7.75 per share, set against $7.0 million of quarterly operating burn.

The market has treated the story harshly. Shares entered the report at $5.70, down 48.2% from the $11.00 open following the August report and 58.6% below the 200-day moving average of $13.77. The stock peaked at $16.15 on September 8 and then fell to a 52-week low of $4.35 on November 10, just two days before results. It has since bounced about 31% off that low. Investor sentiment of -0.73 is deeply negative. The Earnings Whispers trend readings are mostly negative on price and AVWAP, although momentum has turned positive alongside the late rebound. That is a sharply defensive backdrop for a company that just met its stated milestones.

The bottom line is that Corvex delivered on process but not yet on proof. Capacity is secured, Token Factory is live, pricing commentary improved and the balance sheet was recapitalized. Live ARR, however, stalled, losses widened and the shareholder base keeps expanding. The investment case now rests almost entirely on converting the Mid-Atlantic Blackwell deal and the Midwest-1 offtake into signed, commissioned, revenue-generating contracts. Until that happens, deeply negative sentiment and a stock trading near its lows reflect a reasonable level of skepticism.